Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience

被引：0
|
作者：
Omarini, C. [1 ]
Medici, G. [1 ]
Guaitoli, G. [1 ]
Iattoni, E. [1 ]
Moscetti, L. [1 ]
Balduzzi, S. [1 ]
Cascinu, S. [1 ]
Piacentini, F. [1 ]
机构：
[1] Univ Modena Policlin, Modena, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw337.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
F55
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
    Ma, Bo
    Ma, Qianqian
    Wang, Hongqiang
    Zhang, Guolei
    Zhang, Huiying
    Wang, Xiaohong
    ONCOTARGETS AND THERAPY, 2016, 9 : 959 - 976
  • [2] T-DM1 for HER2 positive advanced breast cancer: a single institution, "real life" experience
    Bertolini, I.
    Ferrarini, I.
    Fancelli, S.
    De Angelis, C.
    Fontana, A.
    Salvadori, B.
    Landucci, E.
    Michelotti, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 20 - 21
  • [3] T-DM1 for HER2-positive metastatic breast cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (03): : E94 - E94
  • [4] Italian observational study on T-DM1 in HER2 positive advanced breast cancer patients: real world effectiveness and safety
    Fabi, A.
    Alesini, D.
    De laurentiis, M.
    Valle, E.
    Santini, D.
    Cannita, K.
    Carbognin, L.
    Ciccarese, M.
    Arpino, G.
    Leonardi, V.
    Montemurro, F.
    La Verde, N.
    Generali, D. G.
    Scandurra, G.
    Russillo, M.
    Paris, I.
    D'Ottavio, A. M.
    Filippelli, G.
    Stani, S.
    Giannarelli, D.
    Cognetti, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Efficacy of T-DM1 in patients with HER2-positive metastatic breast cancer previously treated with pertuzumab
    Matsui, K.
    Yoshikawa, A.
    Oyama, K.
    Nozaki, Z.
    Tanada, Y.
    Earashi, M.
    Kiyohara, K.
    Nagata, T.
    Fukushima, W.
    Shimizu, T.
    Maeda, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] The safety and efficacy profiling of T-DM1 treatments of metastatic breast cancer patients
    Iwasa, Tsutomu
    Nakagawa, Kazuhiko
    Tsurutani, Junji
    Nishida, Satomi
    Komoike, Yoshifumi
    Hashimoto, Yukihiko
    Azumi, Tatsuya
    Shinzaki, Wataru
    ANNALS OF ONCOLOGY, 2015, 26 : 127 - 127
  • [7] HER2 expression and efficacy of T-DM1
    Montemurro, Filippo
    BREAST CANCER RESEARCH, 2014, 16 (06):
  • [8] HER2 expression and efficacy of T-DM1
    Filippo Montemurro
    Breast Cancer Research, 16
  • [9] Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
    Jacot, William
    Pons, Elvire
    Frenel, Jean-Sebastien
    Guiu, Severine
    Levy, Christelle
    Heudel, Pierre Etienne
    Bachelot, Thomas
    D'Hondt, Veronique
    Darlix, Amelie
    Firmin, Nelly
    Romieu, Gilles
    Thezenas, Simon
    Dalenc, Florence
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (02) : 307 - 318
  • [10] Complete Cerebrospinal Fluid Response to T-DM1 in HER2 Positive Metastatic Breast Cancer: A Case Report
    Zacchi, Francesca
    Giontella, Elena
    Nottegar, Alessia
    Fiorio, Elena
    LIFE-BASEL, 2023, 13 (03):
12345